Xiaojun Yao

Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer

Nan Jin, Aiwei Bi, Xiaojing Lan et al. · Nature Communications · 2019 · 143 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway

Chunli Wei, Xiaojun Yao, Zebo Jiang et al. · Pharmacological Research · 2019 · 99 citations

Medicine, Oncology, Pharmacology +12

MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3′UTR and predicts poor survival in non-small cell lung cancer

Fu‐Gang Duan, Meifang Wang, Yabing Cao et al. · Cell Death and Disease · 2019 · 91 citations · Full text

Medicine, Molecular Biology, Oncology +17

p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling

Yize Zhang, Chae Young Han, Fu Gang Duan et al. · Cancer Cell International · 2019 · 79 citations · Full text

Medicine, Cancer Biology, Oncology +17

Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer

Lei Zhao, Lai-Han Leung, Jing Wang et al. · BMC Pulmonary Medicine · 2017 · 78 citations · Full text

Medicine, Oncology, Epidemiology +15